Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
AVAH 
Aveanna Healthcare Holdings Inc (AVAH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: AVAH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
8 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $7.56
1 Year Target Price $7.56
| 1 | Strong Buy |
| 0 | Buy |
| 5 | Hold |
| 1 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -10.42% | Avg. Invested days 29 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.64B USD | Price to earnings Ratio 87.11 | 1Y Target Price 7.56 |
Price to earnings Ratio 87.11 | 1Y Target Price 7.56 | ||
Volume (30-day avg) 8 | Beta 1.96 | 52 Weeks Range 3.67 - 8.04 | Updated Date 08/29/2025 |
52 Weeks Range 3.67 - 8.04 | Updated Date 08/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.09 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-08-07 | When - | Estimate 0.04 | Actual 0.18 |
Profitability
Profit Margin 0.85% | Operating Margin (TTM) 14.15% |
Management Effectiveness
Return on Assets (TTM) 8.12% | Return on Equity (TTM) -547.92% |
Valuation
Trailing PE 87.11 | Forward PE 19.34 | Enterprise Value 2859507564 | Price to Sales(TTM) 0.75 |
Enterprise Value 2859507564 | Price to Sales(TTM) 0.75 | ||
Enterprise Value to Revenue 1.31 | Enterprise Value to EBITDA 12.67 | Shares Outstanding 208896000 | Shares Floating 57711801 |
Shares Outstanding 208896000 | Shares Floating 57711801 | ||
Percent Insiders 5.67 | Percent Institutions 88.81 |
Upturn AI SWOT
Aveanna Healthcare Holdings Inc
Company Overview
History and Background
Aveanna Healthcare Holdings Inc. was formed in 2017 through the merger of Epic Health Services and PSA Healthcare. It provides a range of home healthcare services, focusing on medically complex children and adults. The company has grown through acquisitions and organic expansion.
Core Business Areas
- Home Health and Hospice: Provides skilled nursing, therapy, and hospice care to patients in their homes. This segment caters to both adult and pediatric populations.
- Private Duty Services: Offers continuous, hourly care provided by nurses and home health aides for medically fragile individuals, primarily children.
- Developmental Therapy Services: Provides therapy services, including speech, occupational, and physical therapy, to children with developmental delays or disabilities.
- Physician Home Visits: Provides in home physician visits for primary care and other medical needs. This service is primarily for individuals that cannot easily visit a doctor's office.
Leadership and Structure
Tony Strange serves as the CEO. The company operates with a corporate structure overseeing regional and local operations, with a board of directors providing governance.
Top Products and Market Share
Key Offerings
- Private Duty Nursing (PDN): Provides continuous skilled nursing care in patients' homes, primarily for children with complex medical needs. Aveanna is a major player in this fragmented market. Competitors include Maxim Healthcare Services and BAYADA Home Health Care. Precise market share data is not publicly available but is significant.
- Home Health: Offers a range of skilled nursing, therapy, and personal care services to adults and children at home. Competitors include LHC Group (LHCG) and Amedisys (AMED). Market share data isn't explicitly stated for Aveanna alone but falls under the broader home healthcare industry.
- Hospice Care: Provides end-of-life care services focused on comfort and quality of life for terminally ill patients. Competitors include Gentiva Health Services and VITAS Healthcare. Market share isn't explicitly stated.
- Therapy Services: Offers physical, occupational, and speech therapy for pediatric patients in the home. Competitors include early intervention therapy providers and other home health agencies. Market share is not explicitly stated.
Market Dynamics
Industry Overview
The home healthcare industry is experiencing growth due to the aging population, increasing prevalence of chronic diseases, and a preference for home-based care. Technological advancements, such as telehealth, are also shaping the industry.
Positioning
Aveanna is a large player in the complex home healthcare market, particularly for pediatric care. Its competitive advantages include its scale, specialized services, and focus on medically complex patients.
Total Addressable Market (TAM)
The home healthcare market is projected to reach hundreds of billions of dollars. Aveanna is positioned to capture a significant portion of this TAM due to its specialization in complex care and its nationwide presence.
Upturn SWOT Analysis
Strengths
- Large Scale and National Footprint
- Specialized Pediatric Care Expertise
- Diversified Service Offerings
- Established Relationships with Payers
Weaknesses
- High Labor Costs
- Reliance on Government Reimbursement
- Integration Challenges from Acquisitions
- High Debt Levels
Opportunities
- Expanding Home Healthcare Market
- Increasing Demand for Pediatric Care
- Technological Advancements (Telehealth)
- Strategic Acquisitions
Threats
- Changes in Reimbursement Policies
- Increased Competition
- Labor Shortages
- Regulatory Scrutiny
Competitors and Market Share
Key Competitors
- LHCG
- AMED
- OTLY
Competitive Landscape
Aveanna has a strong position in pediatric home healthcare but faces competition from larger, more diversified home healthcare providers. Aveanna's focus on complex care provides a niche advantage. OTLY is an outier but still provides some home based pediatric services.
Major Acquisitions
Maxim Healthcare Services Pediatric Division
- Year: 2019
- Acquisition Price (USD millions): 200
- Strategic Rationale: Expanded Aveanna's pediatric home healthcare service offerings and geographic reach.
Growth Trajectory and Initiatives
Historical Growth: Aveanna has historically grown through acquisitions and organic expansion, particularly in the pediatric home healthcare market.
Future Projections: Future growth is expected to be driven by the increasing demand for home healthcare services and continued strategic acquisitions. Analyst estimates vary, but generally project revenue growth.
Recent Initiatives: Recent initiatives include focusing on operational efficiencies, expanding service lines (e.g., telehealth), and pursuing strategic acquisitions.
Summary
Aveanna Healthcare is a leading provider of complex home healthcare, particularly for pediatric patients, and has grown through acquisitions. While its revenue has increased, profitability is a challenge due to expenses and reimbursement pressures. The company faces threats from regulatory changes and labor shortages but also has opportunities to expand its services and geographic reach. It must manage its debt effectively and focus on operational efficiencies to improve financial performance.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Investor Presentations
- Industry Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market data can vary and is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aveanna Healthcare Holdings Inc
Exchange NASDAQ | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2021-04-28 | CEO & Director Mr. Jeffrey S. Shaner | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 33500 | Website https://www.aveanna.com |
Full time employees 33500 | Website https://www.aveanna.com | ||
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.